期刊文献+

药物洗脱支架术后极晚期血栓形成原因及防治进展

Causes and progress of prevention and treatment for very late stent thrombosis after drug-eluting stent implantation
下载PDF
导出
摘要 药物洗脱支架能有效减少支架再狭窄率和靶血管的再次血运重建,但与金属裸支架相比,药物洗脱支架极晚期血栓(VLST)发生率呈上升趋势。研究显示药物洗脱支架术后再内皮化延迟、抗血小板药物抵抗、PCI操作技术与晚期血栓形成有密切相关。本文就VLST形成原因、危险因素及防治策略作以下综述。 Drug-eluting stent can effectively decrease stent restenosis rate and revascularization of target vessels,but compared With bare-metal stent, there Was an increasing trend in incidence rate of very late stent thrombosis (VLST).Some study indicated that delayed re-endothelialization,anti-platelet drug resistance after drug-eluting stent thrombosis after drug-eluting stent implantation and operation technique of percutaneous coronary intervention (PCI)Were closely related to late thrombosis.This article made folloWing overvieW on cause,risk factors and pre-ventive and therapeutic strategy of VLST.
作者 王春玲
出处 《心血管康复医学杂志》 CAS 2014年第2期221-224,共4页 Chinese Journal of Cardiovascular Rehabilitation Medicine
关键词 血栓形成 支架 血小板聚集抑制剂 Thrombosis Stents Platelet aggregation inhibitors
  • 相关文献

参考文献20

  • 1Kereiakes DJ, Choo JK, Young JJ, etal. Thrombosis anddrug-eluting stents: a critical appraisal[J]. Rev Cardiovasc Med, 2004, 5 (1): 9-15.
  • 2Routledge HC, Lefèvre T, Colombo A, et al. Three-year clinic outcome of percutaneous treatment of bifurcation lesions in mul- tivessel coronary artery disease with the sirolimus-eluting stent: insights from the arterial Revascularisation Therapies Study, Part Ⅱ (ARTS Ⅱ) [J]. EuroIntervention, 2009, 5 (2): 190-196.
  • 3Mauri L, Hsieh WH, MassarO 3M, et al. Stent thrombosis in randomized clinical trials of drug-eluting stents [J]. N Engl J Med, 2007, 356 (10): 1020-1029.
  • 4Armstrong EJ, Feldman DN, Wang TY, et al. Clinical presen- tation, management, and outcome of angiographically docu- mented early, late, and very late stent thrombosis [J]. JACC CardiolInterv, 2012, 5 (2): 131-140.
  • 5Brodie B, Pokharel Y, Fleishman N, et al. Very late stent thrombosis after primary percutaneous coronary intervention with bare-metal and drug-eluting stents for ST-segment ele- vation myocardial infarction: a 15-year single-center experience [J]. JACCCardiolInterv, 2011, 4 (1): 30-38.
  • 6Pfisterer M, Brunner-La Rocca HP, Buser PT, etal. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents., an observational study of drug-e- luting stents versus bare-metal stents [J]. J Am Coll Cardiol, 2006, 48 (12): 2584-2591.
  • 7Jiménez-Valero S, Moreno R, Sfinehez Recalde A. Very late drug-eluting stent thrombosis relate to incomplete stent endothe- lialization: in-vivo demonstration by optical coherence tomo- graphy [J]. J fnvasive Cardiol, 2009, 21 (9): 488-490.
  • 8Virmani R, Guagliumi G, Farb A, et al. Local hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? [J]. Circulation, 2004, 109 (6): 701-705.
  • 9Steffel J, Eberli FR, Luscher TF, et al. Drug-eluting stents- what should be improved? [J]. Ann Med, 2008, 40 (4): 242 -252.
  • 10Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk [J]. J Am Coll Cardiol, 2006, 48 (1): 193-202.

二级参考文献6

  • 1Kuchulakanti P,Chu W,Torguson R,et al.Correlates and long term outcomes of angiographically proven stent thrombosis with sirolimus and paclitaxel eluting stents.Circulation,2006,113:1108-1113.
  • 2Luscher TF,Steffel J,Eberli FR,et al.Drug-eluting stent and coronary thrombosis:Biological mechanisms and clinical implications.Circulation,2007,115:1051-1058.
  • 3Kotani JI,Awata M,Nanto S,et al.Incomplete neointimal coverage of sirolimus eluting stents:Angioscopic findings.J Am Coll Cardiol,2006,47:2108-2111.
  • 4Iakovou I,Schmidt T,Bonizzoni E,et al.Incidence,predictors,and outcome of thrombosis after successful implantation of drug-eluting stents.JAMA,2005,293:2126-2130.
  • 5Virmani R,Guagliumi G,Farb A,et al.Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent:Should we be cautious? Circulation,2004,109:701-705.
  • 6Lee MS,Jurewitz D,Aragon J,et al.Stent fracture associated with drug-eluting stents:Clinical characteristics and implications.Catheter Cardiovasc Interv,2007,69:387-394.

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部